{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:17:27Z","timestamp":1781716647799,"version":"3.54.5"},"reference-count":34,"publisher":"Informa UK Limited","issue":"5-6","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/17512433.2024.2344665","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T10:02:34Z","timestamp":1713348154000},"page":"467-475","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Treatment adherence and adverse event management in chronic lymphocytic leukemia: challenges and strategies for the future"],"prefix":"10.1080","volume":"17","author":[{"given":"Maurlia D.","family":"Upchurch","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, UNC Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyam","family":"Muluneh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, UNC Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01261-9"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2045597"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-737346"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0405"},{"key":"e_1_3_4_7_1","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. chronic lymphocytic leukemia\/small lymphocytic lymphoma: version 3.2023. National Comprehensive Cancer Network; 2023 Sep 15. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf"},{"key":"e_1_3_4_8_1","volume-title":"Package insert","author":"Imbruvica (ibrutinib)","year":"2015","unstructured":"Imbruvica (ibrutinib). Package insert. Sunnyvale, CA: Janssen Biotech, Inc and Pharmacyclics; 2015."},{"key":"e_1_3_4_9_1","volume-title":"Package insert","author":"Jaypirca (pirtobrutinib)","year":"2023","unstructured":"Jaypirca (pirtobrutinib). Package insert. Indianapolis, IN: Eli Lilly; 2023."},{"key":"e_1_3_4_10_1","volume-title":"Package insert","author":"Venclexta (venetoclax)","year":"2016","unstructured":"Venclexta (venetoclax). Package insert. South San Francisco, CA: Genentech; 2016."},{"key":"e_1_3_4_11_1","volume-title":"Package insert","author":"Gazyva(Obintuzumab)","year":"2013","unstructured":"Gazyva(Obintuzumab). Package insert. South San Francisco, CA: Genentech; 2013."},{"key":"e_1_3_4_12_1","volume-title":"Package insert","author":"Zydelig (idelalisib)","year":"2014","unstructured":"Zydelig (idelalisib). Package insert. Foster City, CA: Gilead; 2014."},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1547-5069.2003.tb00001.x"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.17.00039"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2022.100163"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.08.025"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0000000000000452"},{"issue":"5","key":"e_1_3_4_18_1","first-page":"70","article-title":"Care coordination: the role of pharmacy to help manage patients with cancer on oral oncolytics","volume":"36","author":"Oncology Pharmacy Education Network","year":"2021","unstructured":"Oncology Pharmacy Education Network. Care coordination: the role of pharmacy to help manage patients with cancer on oral oncolytics. Association Of Community Cancer Centers (ACCC). 2021;36(5):70\u201374.","journal-title":"Association Of Community Cancer Centers (ACCC)"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.2.210"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/512016"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.018390"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2540"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00483"},{"key":"e_1_3_4_25_1","volume-title":"Package insert","author":"Brukinsa (zanubrutinib)","year":"2019","unstructured":"Brukinsa (zanubrutinib). Package insert. BeiGene USA: Inc.; 2019."},{"key":"e_1_3_4_26_1","volume-title":"Package insert","author":"Calquence (acalabrutinib)","year":"2022","unstructured":"Calquence (acalabrutinib). Package insert. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2022."},{"key":"e_1_3_4_27_1","volume-title":"Package insert","author":"Copiktra (duvelisib)","year":"2018","unstructured":"Copiktra (duvelisib). Package insert. Las Vegas, NV: Secura Bio; 2018."},{"issue":"5","key":"e_1_3_4_28_1","first-page":"1","article-title":"Standardized screening for health-related social needs in clinical settings: the accountable health communities screening tool","volume":"7","author":"Billioux A","year":"2017","unstructured":"Billioux A, DPhil MD, Verlander K, et al. Standardized screening for health-related social needs in clinical settings: the accountable health communities screening tool. Nat Acad Med Persp. 2017;7(5):1\u20139. https:\/\/nam.edu\/wpcontent\/uploads\/2017\/05\/Standardized-Screening-for-Health-Related-Social-Needs-in-Clinical-Settings.pdf","journal-title":"Nat Acad Med Persp"},{"key":"e_1_3_4_29_1","unstructured":"Lexicomp Online. Pediatric and neonatal lexi-drugs online. Waltham (MA): UpToDate Inc.; 2021 Jul 30 [cited 2024 Jan 24]. Available from: https:\/\/online.lexi.com"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216679026"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S224496"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.086066"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20191190415"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10580-4"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2017.07.004"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31733"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2024.2344665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:51:03Z","timestamp":1719517863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2024.2344665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":34,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/17512433.2024.2344665"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2024.2344665","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}